The use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARBS) in patients with AKI during the index hospitalization was not associated with a higher risk of recurrent hospitalized AKI (adjusted hazard ratio, 0.88; 95% confidence interval, 0.69 to 1.13) [24]. Here, ACE is linked to acute kidney injury.